Abstract:Objective: The aim of this study was to evaluate the efficacy of a new ultrasound contrast agent, SonoVue, in diagnosis and differential diagnosis of liver lesions.Methods: Thirty-one patients with difficult differential diagnosis or highly suspected for liver lesions on CT, MRI, or conventional US were studied. A dose of 2.4 ml of SonoVue (Bracco, Italy) was infused intravenously within 30 sec. The enhancement level was monitored with a nonlinear scanning mode using an Acuson Sequoia-512 scanner with 6C-2, 4C-1 probes. The comparison examinations were performed with physical examination in all cases and with library examination in 16 patients before and after SonoVue injection. The histopathalogical diagnoses were obtained in 20 patients after SonoVue enhanced US examination. The other diagnoses were confirmed on CT, MRI, and DSA. Twenty patients had malignant liver lesions (16 hepatocellular carcinomas, 4 metastases), while 11 had benign lesions (4 hemangiomas, 2 focal nodular hyperplasias, 5 others).Results: 1) After SonoVue injection, the number of lesions without flow signal intralesions dropped from 15 to 2 with nonlinear scanning modes. 2) The positive diagnoses compared to the histopathalogical diagnoses increased after SonoVue in nonlinear scanning modes (p<0.05). 3) There was no difference in physical examination and library examinations before and after SonoVue injection.Conclusions: SonoVue is useful in visualizing tumor vessel and characterizing liver tumors. It is a safe, efficient ultrasound contrast agent and convenient for use. Objective: The aim of this study was to evaluate the efficacy of a new ultrasound contrast agent, SonoVue, in diagnosis and differential diagnosis of liver lesions. Methods: Thirty-one patients with difficult differential diagnosis or highly suspected for liver lesions on CT, MRI, or conventional US were studied. A dose of 2.4 ml of SonoVue (Bracco, Italy) was infused intravenously within 30 sec. The enhancement level was monitored with a nonlinear scanning mode using an Acuson Sequoia-512 scanner with 6C-2, 4C-1 probes. The comparison examinations were performed with physical examination in all cases and with library examination in 16 patients before and after SonoVue injection. The histopathalogical diagnoses were obtained in 20 patients after SonoVue enhanced US examination. The other diagnoses were confirmed on CT, MRI, and DSA. Twenty patients had malignant liver lesions (16 hepatocellular carcinomas, 4 metastases), while 11 had benign lesions (4 hemangiomas, 2 focal nodular hyperplasias, 5 others). Results: 1) After SonoVue injection, the number of lesions without flow signal intralesions dropped from 15 to 2 with nonlinear scanning modes. 2) The positive diagnoses compared to the histopathalogical diagnoses increased after SonoVue in nonlinear scanning modes (p<0.05). 3) There was no difference in physical examination and library examinations before and after SonoVue injection. Conclusions: SonoVue is useful in visualizing tumor vessel and characterizing liver tumors. It is a safe, efficient ultrasound contrast agent and convenient for use.

Adverse reactions analysis and safety management associated with SonoVue

Adverse Reactions after the Use of SonoVue Contrast Agent

Safety of Sulfur Hexafluoride Microbubbles in Sonography of Abdominal and Superficial Organs: Retrospective Analysis of 30,222 Cases

Contrast-enhanced ultrasound imaging of the liver: a review of the clinical evidence for SonoVue and Sonazoid

Anaphylaxis after SonoVue: A Case Report and a Literature Review

Prevention and Treatment of Anaphylactoid Reaction to Ionic and Nonionic Iodinated Contrast Media

Safety findings after intravenous administration of sulfur hexafluoride microbubbles to 463,434 examinations at 24 centers

Improved differential diagnosis of focal liver disease using SonoVue with nonlinear scanning mode

A Review of Contrast-enhanced Ultrasound using SonoVue® and Sonazoid TM in Non-hepatic Organs

Safety of Lumason® (SonoVue®) in special populations and critically ill patients

Relationship between volume of bladder and contrast-enhanced ultrasound of Sono Vue

The inertial cavitation characteristics of SonoVue microbubbles mediated by pulsed ultrasound

Retrospective analysis of non-laboratory-based adverse drug reactions induced by intravenous radiocontrast agents in a Joint Commission International-accredited academic medical center hospital in China

Relationship Between Dosage of SonoVue and Image Quality of Liver Occupied Lesions

Managing Adverse Reactions to Contrast Agents

Trends in Adverse Events After IV Administration of Contrast Media

Comparison of SonoVue and Sonazoid in Localization of Sentinel Lymph Nodes in Early Breast Cancer Patients

1265: Application of SonoVue in Sonosalpingography: the Value of Diagnosis of Uterine Tubal Occlusion

Relationship Between Patient-Friendly Audiovisual Systems and MRI Contrast Agent to Adverse Reactions

Effect of SonoVue on Left and Right Ventricle in Pigs

Comparative Safety Profiles and Usage Patterns of Iodinated Contrast Media in Medical Imaging